Artificial Intelligence for Improving Prostate Cancer Management
Wayne Brisbane, MD, explores the integration of AI in focal therapy for prostate cancer management at UCLA.
Read More
2024
Patient Selection for Focal Therapy – Radiologic Perspective
Jurgen Futterer, MD, PhD, focuses on patient selection for prostate cancer focal therapy from a radiological perspective.
Read More
Elevated PSA and Obstructive LUTS
Bilal Chughtai, MD, addresses the relationship between elevated PSA levels and obstructive LUTS.
Read More
Office BPH: 2024 Updates and Where Are We Going?
Kevin Zorn, MD, FRCSC, FACS, explores the evolving approaches to treating benign prostatic hyperplasia (BPH).
Read More
Away from the Gleason Score and Towards Quantification of Pattern 4 for Treatment Decision Making in Localized Prostate Cancer
Andrew Vickers, PhD, discusses the need for reforming the Gleason score, the cornerstone of decision-making in prostate cancer management.
Read More